These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

671 related items for PubMed ID: 30652656

  • 1. Circulating miRNA-21 and miRNA-23a Expression Signature as Potential Biomarkers for Early Detection of Non-Small-Cell Lung Cancer.
    Hetta HF, Zahran AM, Shafik EA, El-Mahdy RI, Mohamed NA, Nabil EE, Esmaeel HM, Alkady OA, Elkady A, Mohareb DA, Hosni A, Mostafa MM, Elkady A.
    Microrna; 2019; 8(3):206-215. PubMed ID: 30652656
    [Abstract] [Full Text] [Related]

  • 2. Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer.
    Hetta HF, Zahran AM, El-Mahdy RI, Nabil EE, Esmaeel HM, Elkady OA, Elkady A, Mohareb DA, Mahmoud Mostafa M, John J.
    Asian Pac J Cancer Prev; 2019 Jun 01; 20(6):1927-1933. PubMed ID: 31244320
    [Abstract] [Full Text] [Related]

  • 3. Potential circulating miRNA signature for early detection of NSCLC.
    Arab A, Karimipoor M, Irani S, Kiani A, Zeinali S, Tafsiri E, Sheikhy K.
    Cancer Genet; 2017 Oct 01; 216-217():150-158. PubMed ID: 29025589
    [Abstract] [Full Text] [Related]

  • 4. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L, Qi H, Teng J, Su B, Chen H, Wang C, Xia Q.
    Tumour Biol; 2016 Jun 01; 37(6):7777-84. PubMed ID: 26695145
    [Abstract] [Full Text] [Related]

  • 5. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
    Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E.
    Lung Cancer; 2013 Sep 01; 81(3):388-396. PubMed ID: 23756108
    [Abstract] [Full Text] [Related]

  • 6. A Novel Serum 4-microRNA Signature for Lung Cancer Detection.
    Nadal E, Truini A, Nakata A, Lin J, Reddy RM, Chang AC, Ramnath N, Gotoh N, Beer DG, Chen G.
    Sci Rep; 2015 Jul 23; 5():12464. PubMed ID: 26202143
    [Abstract] [Full Text] [Related]

  • 7. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
    Yang X, Zhang Q, Zhang M, Su W, Wang Z, Li Y, Zhang J, Beer DG, Yang S, Chen G.
    Int J Biol Sci; 2019 Jul 23; 15(8):1712-1722. PubMed ID: 31360113
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer.
    Su K, Zhang T, Wang Y, Hao G.
    World J Surg Oncol; 2016 Aug 24; 14(1):224. PubMed ID: 27733164
    [Abstract] [Full Text] [Related]

  • 9. [Plasma miRNA-23a and miRNA-451 as candidate biomarkers for early diagnosis of nonsmall cell lung cancer: a case-control study].
    Cui S, Cao Z, Guo W, Yu H, Huang R, Wu Y, Zhou Y.
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jun 30; 39(6):705-711. PubMed ID: 31270050
    [Abstract] [Full Text] [Related]

  • 10. Down-expression of circulating micro ribonucleic acid (miRNA)-148/152 family in plasma samples of non-small cell lung cancer patients.
    Huang MX.
    J Cancer Res Ther; 2016 Jun 30; 12(2):671-5. PubMed ID: 27461630
    [Abstract] [Full Text] [Related]

  • 11. Circulating miRNA panels as a novel non-invasive diagnostic, prognostic, and potential predictive biomarkers in non-small cell lung cancer (NSCLC).
    Abdipourbozorgbaghi M, Vancura A, Radpour R, Haefliger S.
    Br J Cancer; 2024 Nov 30; 131(8):1350-1362. PubMed ID: 39215192
    [Abstract] [Full Text] [Related]

  • 12. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
    Shi GL, Chen Y, Sun Y, Yin YJ, Song CX.
    Clin Lab; 2017 Jan 01; 63(1):133-140. PubMed ID: 28164492
    [Abstract] [Full Text] [Related]

  • 13. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
    Chen X, Xu Y, Liao X, Liao R, Zhang L, Niu K, Li T, Li D, Chen Z, Duan Y, Sun J.
    Tumour Biol; 2016 Sep 01; 37(9):11927-11936. PubMed ID: 27075472
    [Abstract] [Full Text] [Related]

  • 14. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer.
    Guo W, Zhang Y, Zhang Y, Shi Y, Xi J, Fan H, Xu S.
    Int J Mol Med; 2015 Dec 01; 36(6):1720-6. PubMed ID: 26497897
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
    Geng Q, Fan T, Zhang B, Wang W, Xu Y, Hu H.
    Respir Res; 2014 Nov 25; 15(1):149. PubMed ID: 25421010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.